Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Value of Neutrophil to Lymphocyte Ratio and Its Trajectory in Patients Hospitalized With Acute Heart Failure and Preserved Ejection Fraction.

Boralkar KA, Kobayashi Y, Amsallem M, Ataam JA, Moneghetti KJ, Cauwenberghs N, Horne BD, Knowlton KU, Maecker H, Kuznetsova T, Heidenreich PA, Haddad F.

Am J Cardiol. 2019 Oct 26. pii: S0002-9149(19)31167-1. doi: 10.1016/j.amjcard.2019.10.020. [Epub ahead of print]

PMID:
31753313
2.

The 2013 ACC/AHA risk score and subclinical cardiac remodeling and dysfunction: Complementary in cardiovascular disease prediction.

Cauwenberghs N, Hedman K, Kobayashi Y, Vanassche T, Haddad F, Kuznetsova T.

Int J Cardiol. 2019 Oct 9. pii: S0167-5273(19)33585-5. doi: 10.1016/j.ijcard.2019.09.061. [Epub ahead of print]

PMID:
31623873
3.

Workload-indexed blood pressure response is superior to peak systolic blood pressure in predicting all-cause mortality.

Hedman K, Cauwenberghs N, Christle JW, Kuznetsova T, Haddad F, Myers J.

Eur J Prev Cardiol. 2019 Sep 30:2047487319877268. doi: 10.1177/2047487319877268. [Epub ahead of print]

PMID:
31564136
4.

Area of the pressure-strain loop during ejection as non-invasive index of left ventricular performance: a population study.

Cauwenberghs N, Tabassian M, Thijs L, Yang WY, Wei FF, Claus P, D'hooge J, Staessen JA, Kuznetsova T.

Cardiovasc Ultrasound. 2019 Aug 5;17(1):15. doi: 10.1186/s12947-019-0166-y.

5.

Central Hemodynamics in Relation to Circulating Desphospho-Uncarboxylated Matrix Gla Protein: A Population Study.

Wei FF, Thijs L, Cauwenberghs N, Yang WY, Zhang ZY, Yu CG, Kuznetsova T, Nawrot TS, Struijker-Boudier HAJ, Verhamme P, Vermeer C, Staessen JA.

J Am Heart Assoc. 2019 Apr 2;8(7):e011960. doi: 10.1161/JAHA.119.011960.

6.

Circulating Biomarkers Predicting Longitudinal Changes in Left Ventricular Structure and Function in a General Population.

Cauwenberghs N, Ravassa S, Thijs L, Haddad F, Yang WY, Wei FF, López B, González A, Díez J, Staessen JA, Kuznetsova T.

J Am Heart Assoc. 2019 Jan 22;8(2):e010430. doi: 10.1161/JAHA.118.010430.

7.

Temporal changes in left ventricular longitudinal strain in general population: Clinical correlates and impact on cardiac remodeling.

Kuznetsova T, Nijs E, Cauwenberghs N, Knez J, Thijs L, Haddad F, Yang WY, Kerkhof PL, Voigt JU, Staessen JA.

Echocardiography. 2019 Mar;36(3):458-468. doi: 10.1111/echo.14246. Epub 2019 Jan 4.

PMID:
30609050
8.

Inactive matrix Gla protein is a novel circulating biomarker predicting retinal arteriolar narrowing in humans.

Wei FF, Huang QF, Zhang ZY, Van Keer K, Thijs L, Trenson S, Yang WY, Cauwenberghs N, Mujaj B, Kuznetsova T, Allegaert K, Struijker-Boudier HAJ, Verhamme P, Vermeer C, Staessen JA.

Sci Rep. 2018 Oct 10;8(1):15088. doi: 10.1038/s41598-018-33257-6.

9.

Sex-specific differences in cardiac maladaptation to hypertension and arterial stiffening.

Cauwenberghs N, Kuznetsova T.

Kardiol Pol. 2018;76(9):1303-1311. doi: 10.5603/KP.a2018.0158. Epub 2018 Aug 9. Review.

10.

Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction.

Zhang ZY, Nkuipou-Kenfack E, Yang WY, Wei FF, Cauwenberghs N, Thijs L, Huang QF, Feng YM, Schanstra JP, Kuznetsova T, Voigt JU, Verhamme P, Mischak H, Staessen JA.

J Am Soc Hypertens. 2018 Jun;12(6):438-447.e4. doi: 10.1016/j.jash.2018.03.007. Epub 2018 Mar 21.

11.

Relation of Insulin Resistance to Longitudinal Changes in Left Ventricular Structure and Function in a General Population.

Cauwenberghs N, Knez J, Thijs L, Haddad F, Vanassche T, Yang WY, Wei FF, Staessen JA, Kuznetsova T.

J Am Heart Assoc. 2018 Mar 24;7(7). pii: e008315. doi: 10.1161/JAHA.117.008315.

12.

Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.

Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, Taylor DA, Yang PC.

Sci Rep. 2018 Mar 6;8(1):4257. doi: 10.1038/s41598-018-22121-2.

13.

Ambulatory blood pressure and long-term risk for atrial fibrillation.

Tikhonoff V, Kuznetsova T, Thijs L, Cauwenberghs N, Stolarz-Skrzypek K, Seidlerová J, Malyutina S, Gilis-Malinowska N, Swierblewska E, Kawecka-Jaszcz K, Filipovský J, Narkiewicz K, Lip GYH, Casiglia E, Staessen JA; European Project On Genes in Hypertension (EPOGH) Investigators.

Heart. 2018 Aug;104(15):1263-1270. doi: 10.1136/heartjnl-2017-312488. Epub 2018 Feb 9.

PMID:
29440183
14.

Conventional and Ambulatory Blood Pressure as Predictors of Diastolic Left Ventricular Function in a Flemish Population.

Wei FF, Yang WY, Thijs L, Zhang ZY, Cauwenberghs N, Van Keer J, Huang QF, Mujaj B, Kuznetsova T, Allegaert K, Verhamme P, Staessen JA.

J Am Heart Assoc. 2018 Feb 8;7(4). pii: e007868. doi: 10.1161/JAHA.117.007868.

15.

Doppler indexes of left ventricular systolic and diastolic function in relation to haemodynamic load components in a general population.

Cauwenberghs N, Knez J, Boggia J, D'hooge J, Yang WY, Wei FF, Thijs L, Staessen JA, Kuznetsova T.

J Hypertens. 2018 Apr;36(4):867-875. doi: 10.1097/HJH.0000000000001623.

PMID:
29176509
16.

Correlation Between Mitochondrial DNA Content Measured in Myocardium and Peripheral Blood of Patients with Non-Ischemic Heart Failure.

Knez J, Lakota K, Božič N, Okrajšek R, Cauwenberghs N, Thijs L, Kneževič I, Vrtovec B, Tomšič M, Čučnik S, Sodin-Šemrl S, Kuznetsova T, Brguljan-Hitij J.

Genet Test Mol Biomarkers. 2017 Dec;21(12):736-741. doi: 10.1089/gtmb.2017.0099. Epub 2017 Oct 31.

PMID:
29087733
17.

Peripheral blood mitochondrial DNA content in relation to circulating metabolites and inflammatory markers: A population study.

Knez J, Marrachelli VG, Cauwenberghs N, Winckelmans E, Zhang Z, Thijs L, Brguljan-Hitij J, Plusquin M, Delles C, Monleon D, Redón J, Staessen JA, Nawrot TS, Kuznetsova T.

PLoS One. 2017 Jul 13;12(7):e0181036. doi: 10.1371/journal.pone.0181036. eCollection 2017.

18.

Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.

Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, Taylor DA, Yang PC.

Sci Rep. 2017 Jun 30;7(1):4419. doi: 10.1038/s41598-017-04801-7. Erratum in: Sci Rep. 2018 Mar 6;8(1):4257.

19.

Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.

Li X, Kuznetsova T, Cauwenberghs N, Wheeler M, Maecker H, Wu JC, Haddad F, Dai H.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7089-7094. doi: 10.1073/pnas.1621457114. Epub 2017 Jun 19.

20.

Left ventricular function in relation to chronic residential air pollution in a general population.

Yang WY, Zhang ZY, Thijs L, Bijnens EM, Janssen BG, Vanpoucke C, Lefebvre W, Cauwenberghs N, Wei FF, Luttun A, Verhamme P, Van Hecke E, Kuznetsova T, D'hooge J, Nawrot TS, Staessen JA.

Eur J Prev Cardiol. 2017 Sep;24(13):1416-1428. doi: 10.1177/2047487317715109. Epub 2017 Jun 15.

21.

Ibuprofen exposure in early neonatal life does not affect renal function in young adolescence.

Raaijmakers A, Zhang ZY, Levtchenko E, Simons SH, Cauwenberghs N, Heuvel LPVD, Jacobs L, Staessen JA, Allegaert K.

Arch Dis Child Fetal Neonatal Ed. 2018 Mar;103(2):F107-F111. doi: 10.1136/archdischild-2017-312922. Epub 2017 Jun 14.

PMID:
28615304
22.

PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish population.

Yang WY, Petit T, Cauwenberghs N, Zhang ZY, Sheng CS, Thijs L, Salvi E, Izzi B, Vandenbriele C, Wei FF, Gu YM, Jacobs L, Citterio L, Delli Carpini S, Barlassina C, Cusi D, Hoylaerts MF, Verhamme P, Kuznetsova T, Staessen JA.

BMC Med Genet. 2017 Apr 27;18(1):45. doi: 10.1186/s12881-017-0411-x.

23.

The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population.

Wei FF, Thijs L, Zhang ZY, Jacobs L, Yang WY, Salvi E, Citterio L, Cauwenberghs N, Kuznetsova T, E A Drummen N, Hara A, Manunta P, Li Y, Verhamme P, Allegaert K, Cusi D, Vermeer C, Staessen JA.

Nephrol Dial Transplant. 2018 Mar 1;33(3):514-522. doi: 10.1093/ndt/gfx014.

PMID:
28340119
24.

Longitudinal Changes in LV Structure and Diastolic Function in Relation to Arterial Properties in General Population.

Cauwenberghs N, Knez J, D'hooge J, Thijs L, Yang WY, Wei FF, Zhang ZY, Staessen JA, Kuznetsova T.

JACC Cardiovasc Imaging. 2017 Nov;10(11):1307-1316. doi: 10.1016/j.jcmg.2016.10.018. Epub 2017 Mar 15.

25.

Left Ventricular Structure and Function in Relation to Environmental Exposure to Lead and Cadmium.

Yang WY, Zhang ZY, Thijs L, Cauwenberghs N, Wei FF, Jacobs L, Luttun A, Verhamme P, Kuznetsova T, Nawrot TS, Staessen JA.

J Am Heart Assoc. 2017 Feb 1;6(2). pii: e004692. doi: 10.1161/JAHA.116.004692.

26.

Does Extremely Low Birth Weight Predispose to Low-Renin Hypertension?

Raaijmakers A, Zhang ZY, Claessens J, Cauwenberghs N, van Tienoven TP, Wei FF, Jacobs L, Levtchenko E, Pauwels S, Kuznetsova T, Allegaert K, Staessen JA.

Hypertension. 2017 Mar;69(3):443-449. doi: 10.1161/HYPERTENSIONAHA.116.08643. Epub 2017 Jan 23.

PMID:
28115515
27.

Retinal microvascular diameter, a hypertension-related trait, in ECG-gated vs. non-gated images analyzed by IVAN and SIVA.

Wei FF, Zhang ZY, Petit T, Cauwenberghs N, Gu YM, Thijs L, Raaijmakers A, Jacobs L, Yang WY, Allegaert K, Kuznetsova T, Verhamme P, Struijker-Boudier HA, Li Y, Asayama K, Staessen JA.

Hypertens Res. 2016 Dec;39(12):886-892. doi: 10.1038/hr.2016.81. Epub 2016 Jul 7.

PMID:
27383509
28.

Additive Prognostic Value of Left Ventricular Systolic Dysfunction in a Population-Based Cohort.

Kuznetsova T, Cauwenberghs N, Knez J, Yang WY, Herbots L, D'hooge J, Haddad F, Thijs L, Voigt JU, Staessen JA.

Circ Cardiovasc Imaging. 2016 Jul;9(7). pii: e004661. doi: 10.1161/CIRCIMAGING.116.004661.

PMID:
27329778
29.

Conventional and Ambulatory Blood Pressure as Predictors of Retinal Arteriolar Narrowing.

Wei FF, Zhang ZY, Thijs L, Yang WY, Jacobs L, Cauwenberghs N, Gu YM, Kuznetsova T, Allegaert K, Verhamme P, Li Y, Struijker-Boudier HA, Staessen JA.

Hypertension. 2016 Aug;68(2):511-20. doi: 10.1161/HYPERTENSIONAHA.116.07523. Epub 2016 Jun 20.

30.

Determinants and Prognostic Significance of the Renal Resistive Index.

Cauwenberghs N, Kuznetsova T.

Pulse (Basel). 2016 Apr;3(3-4):172-8. doi: 10.1159/000442445. Epub 2016 Jan 9. Review.

31.

Association of left ventricular structure and function with peripheral blood mitochondrial DNA content in a general population.

Knez J, Cauwenberghs N, Thijs L, Winckelmans E, Brguljan-Hitij J, Yang WY, Staessen JA, Nawrot TS, Kuznetsova T.

Int J Cardiol. 2016 Jul 1;214:180-8. doi: 10.1016/j.ijcard.2016.03.090. Epub 2016 Mar 25.

PMID:
27064638
32.

Doppler indexes of left ventricular systolic and diastolic function in relation to the arterial stiffness in a general population.

Cauwenberghs N, Knez J, Tikhonoff V, D'hooge J, Kloch-Badelek M, Thijs L, Stolarz-Skrzypek K, Haddad F, Wojciechowska W, Swierblewska E, Casiglia E, Kawecka-Jaszcz K, Narkiewicz K, Staessen JA, Kuznetsova T; European Project On Genes in Hypertension (EPOGH) Investigators.

J Hypertens. 2016 Apr;34(4):762-71. doi: 10.1097/HJH.0000000000000854.

PMID:
26828786
33.

Correlates of Peripheral Blood Mitochondrial DNA Content in a General Population.

Knez J, Winckelmans E, Plusquin M, Thijs L, Cauwenberghs N, Gu Y, Staessen JA, Nawrot TS, Kuznetsova T.

Am J Epidemiol. 2016 Jan 15;183(2):138-46. doi: 10.1093/aje/kwv175. Epub 2015 Dec 24.

34.

Cytokines profile in hypertensive patients with left ventricular remodeling and dysfunction.

Kuznetsova T, Haddad F, Knez J, Rosenberg-Hasson Y, Sung J, Cauwenberghs N, Thijs L, Karakikes I, Maecker H, Mahaffey KW, Wu JC, Staessen JA.

J Am Soc Hypertens. 2015 Dec;9(12):975-84.e3. doi: 10.1016/j.jash.2015.10.003. Epub 2015 Oct 17.

PMID:
26565110
35.

Renal glomerular dysfunction in relation to retinal arteriolar narrowing and high pulse pressure in seniors.

Gu YM, Petit T, Wei FF, Thijs L, Jacobs L, Zhang ZY, Yang WY, Cauwenberghs N, Knez J, Struijker-Boudier HA, Kuznetsova T, Verhamme P, Staessen JA.

Hypertens Res. 2016 Mar;39(3):138-43. doi: 10.1038/hr.2015.125. Epub 2015 Nov 12.

PMID:
26559607
36.

Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population.

Yang WY, Petit T, Thijs L, Zhang ZY, Jacobs L, Hara A, Wei FF, Salvi E, Citterio L, Delli Carpini S, Gu YM, Knez J, Cauwenberghs N, Barcella M, Barlassina C, Manunta P, Coppiello G, Aranguren XL, Kuznetsova T, Cusi D, Verhamme P, Luttun A, Staessen JA.

BMC Genet. 2015 Oct 1;16:116. doi: 10.1186/s12863-015-0272-2.

37.

Longitudinal changes in left ventricular diastolic function in a general population.

Kuznetsova T, Thijs L, Knez J, Cauwenberghs N, Petit T, Gu YM, Zhang Z, Staessen JA.

Circ Cardiovasc Imaging. 2015 Apr;8(4). pii: e002882. doi: 10.1161/CIRCIMAGING.114.002882.

PMID:
25873723
38.

Doppler indexes of left ventricular systolic and diastolic flow and central pulse pressure in relation to renal resistive index.

Kuznetsova T, Cauwenberghs N, Knez J, Thijs L, Liu YP, Gu YM, Staessen JA.

Am J Hypertens. 2015 Apr;28(4):535-45. doi: 10.1093/ajh/hpu185. Epub 2014 Sep 20.

PMID:
25241047
39.

Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics.

Deckmyn H, Cauwenberghs N, Wu D, Depraetere H, Vanhoorelbeke K.

Verh K Acad Geneeskd Belg. 2005;67(1):55-65. Review.

PMID:
15828307
40.

A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.

Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.

Semin Thromb Hemost. 2002 Apr;28(2):161-6.

PMID:
11992239
41.

Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.

Wu D, Vanhoorelbeke K, Cauwenberghs N, Meiring M, Depraetere H, Kotze HF, Deckmyn H.

Blood. 2002 May 15;99(10):3623-8.

PMID:
11986216
42.

Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons.

Wu D, Meiring M, Kotze HF, Deckmyn H, Cauwenberghs N.

Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):323-8.

PMID:
11834536
43.

Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.

Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Westra DF, Romo G, Huizinga EG, Lopez JA, Berndt MC, Harsfalvi J, Deckmyn H.

Blood. 2001 Aug 1;98(3):652-60.

PMID:
11468163
44.

Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.

Cauwenberghs N, Schlammadinger A, Vauterin S, Cooper S, Descheemaeker G, Tornai I, Deckmyn H.

Thromb Haemost. 2001 Apr;85(4):679-85.

PMID:
11341505
45.

Structural determinants within platelet glycoprotein Ibalpha involved in its binding to von Willebrand factor.

Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Deckmyn H.

Platelets. 2000 Nov;11(7):373-8. Review.

PMID:
11132103
46.

Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.

Cauwenberghs N, Ajzenberg N, Vauterin S, Hoylaerts MF, Declerck PJ, Baruch D, Deckmyn H.

Haemostasis. 2000 May-Jun;30(3):139-48.

PMID:
11014964
47.

Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates.

Cauwenberghs N, Meiring M, Vauterin S, van Wyk V, Lamprecht S, Roodt JP, Novák L, Harsfalvi J, Deckmyn H, Kotzé HF.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1347-53.

PMID:
10807753
48.

Acquired Bernard-Soulier syndrome: a case with necrotizing vasculitis and thrombosis.

Tornai I, Boda Z, Schlammadinger A, Juhasz A, Cauwenberghs N, Deckmyn H, Harsfalvi J.

Haemostasis. 1999;29(4):229-36.

PMID:
10702705
49.

A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor.

Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H.

Thromb Haemost. 2000 Jan;83(1):107-13.

PMID:
10669163
50.

A platelet-activating antiglycoprotein Ib monoclonal antibody.

Deckmyn H, Vanhoorelbeke K, Cauwenberghs N.

Blood. 1997 Nov 1;90(9):3807-8. No abstract available.

PMID:
9345070

Supplemental Content

Loading ...
Support Center